Napoleone Ferrara
Napoleone Ferrara (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers. Ferrara's work l
2013 in scienceAlfred P. Sloan Jr. PrizeBevacizumabBreakthrough Prize in Life SciencesCanada Gairdner International AwardChampalimaud_FoundationCharles S. Mott PrizeClarivate Citation LaureatesDr. Paul Janssen Award for Biomedical ResearchFerrara (surname)Grand Prix scientifique de la Fondation Lefoulon-DelalandeHarold F. DvorakJoan MillerJudah FolkmanKettering PrizeLasker-DeBakey Clinical Medical Research AwardLasker AwardList of Italian inventions and discoveriesList of members of the National Academy of MedicineList of members of the National Academy of Sciences (Medical genetics, hematology, and oncology)Passano Foundation
Link from a Wikipage to another Wikipage
primaryTopic
Napoleone Ferrara
Napoleone Ferrara (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers. Ferrara's work l
has abstract
Napoleone Ferrara (* 26. Juli ...... sity of California, San Diego.
@de
Napoleone Ferrara (Catania, 26 ...... rescita vascolare endoteliale.
@it
Napoleone Ferrara (Catânia, 26 ...... molecular ítalo-etadunidense.
@pt
Napoleone Ferrara (born 26 Jul ...... aocular neovascular disorders.
@en
Наполеоне Феррара (англ. Napol ...... тва бевацизумаб и ранибизумаб.
@ru
Наполеоне Феррара (італ. Napol ...... іки Бевацизумаб і Ранібізумаб.
@uk
نابليون فيرارا (بالإنجليزية: N ...... ليو 1956 في قطانية في إيطاليا.
@ar
纳波莱奥内·费拉拉(意大利语:Napoleone Ferra ...... 血管生成研究人员,任职于加利福尼亚州的生物技术公司基因泰克。
@zh
birth date
1956-07-26
institution
known for
Wikipage page ID
20,812,145
page length (characters) of wiki page
Wikipage revision ID
1,003,848,838
Link from a Wikipage to another Wikipage
alma mater
@en
University of Catania
@en
awards
@en
Breakthrough Prize
@en
Lasker Award
@en
birth date
1956-07-26
known for
VEGF discovery
@en
wikiPageUsesTemplate
workplaces
@en
Genentech
@en
UC San Diego
@en
subject
hypernym
sameAs
comment
Napoleone Ferrara (* 26. Juli ...... sity of California, San Diego.
@de
Napoleone Ferrara (Catania, 26 ...... rescita vascolare endoteliale.
@it
Napoleone Ferrara (Catânia, 26 ...... molecular ítalo-etadunidense.
@pt
Napoleone Ferrara (born 26 Jul ...... y of cancers. Ferrara's work l
@en
Наполеоне Феррара (англ. Napol ...... тва бевацизумаб и ранибизумаб.
@ru
Наполеоне Феррара (італ. Napol ...... іки Бевацизумаб і Ранібізумаб.
@uk
نابليون فيرارا (بالإنجليزية: N ...... ليو 1956 في قطانية في إيطاليا.
@ar
纳波莱奥内·费拉拉(意大利语:Napoleone Ferra ...... 血管生成研究人员,任职于加利福尼亚州的生物技术公司基因泰克。
@zh
label
Napoleone Ferrara
@de
Napoleone Ferrara
@en
Napoleone Ferrara
@it
Napoleone Ferrara
@pt
Наполеоне Феррара
@uk
Феррара, Наполеоне
@ru
نابليون فيرارا
@ar
纳波莱奥内·费拉拉
@zh